Mesenchymal Stem Cells Decrease Cd14++cd16+Monocytes Of Sepsis Patients Via Prostaglandin E2

被引：0
|
作者：
Qiu, G. [1 ]
Huang, L. [2 ]
Zheng, G. [2 ]
Ge, M. [2 ]
Lai, D. [1 ]
Shu, Q. [1 ]
Xu, J. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China
[2] Shaoxing Second Hosp, Shaoxing, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6765
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adipose-derived mesenchymal stem cells modulate CD14++CD16+ expression on monocytes from sepsis patients in vitro via prostaglandin E2
    Guanguan Qiu
    Guoping Zheng
    Menghua Ge
    Lanfang Huang
    Haijiang Tong
    Ping Chen
    Dengming Lai
    Yaoqin Hu
    Baoli Cheng
    Qiang Shu
    Jianguo Xu
    Stem Cell Research & Therapy, 8
  • [2] Adipose-derived mesenchymal stem cells modulate CD14++ CD16+ expression on monocytes from sepsis patients in vitro via prostaglandin E2
    Qiu, Guanguan
    Zheng, Guoping
    Ge, Menghua
    Huang, Lanfang
    Tong, Haijiang
    Chen, Ping
    Lai, Dengming
    Hu, Yaoqin
    Cheng, Baoli
    Shu, Qiang
    Xu, Jianguo
    STEM CELL RESEARCH & THERAPY, 2017, 8
  • [3] CD14++CD16+MONOCYTES ARE PREDICTORS OF CARDIOVASCULAR OUTCOME
    Rogacev, Kyrill
    Cremers, Bodo
    Zawada, Adam
    Seiler, Sarah
    Binder, Nadine
    Ege, Philipp
    Grosse-Dunker, Gunnar
    Heisel, Isabel
    Hornof, Florian
    Jeken, Jana
    Rebling, Niko
    Ulrich, Christof
    Scheller, Bruno
    Boehm, Michael
    Fliser, Danilo
    Heine, Gunnar Henrik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 396 - 396
  • [4] Intermediate CD14++CD16+monocytes predict cardiovascular outcome
    Rogacev, K.
    Cremers, B.
    Zawada, A.
    Seiler, S.
    Nadine, N.
    Ulrich, C.
    Scheller, B.
    Boehm, M.
    Fliser, D.
    Heine, G.
    EUROPEAN HEART JOURNAL, 2012, 33 : 445 - 445
  • [5] CD14++CD16+Monocytes predict cardiovascular, but not renal Events
    Michel, A.
    Zawada, A.
    Rogacev, K.
    Seiler, S.
    Emrich, I.
    Untersteller, K.
    Lennartz, C.
    Fliser, D.
    Heine, G.
    INTERNIST, 2015, 56 : 45 - 45
  • [6] Inflammatory CD14++CD16+monocytes contribute to atherosclerosis in type 2 diabetes
    Nakamura, M.
    Motoyama, K.
    Kawarabayashi, R.
    Okute, Y.
    Asada, M.
    Kakutani, Y.
    Yamazaki, Y.
    Morioka, T.
    Mori, K.
    Fukumoto, S.
    Shoji, T.
    Emoto, M.
    Inaba, M.
    DIABETOLOGIA, 2016, 59 : S526 - S527
  • [7] Decrease in CD14++CD16+Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline Inflammation
    Caballero, Abelardo
    Vazquez-Sanchez, Teresa
    Ruiz-Esteban, Pedro
    Leon, Myriam
    Alonso-Titos, Juana
    Lopez, Veronica
    Sola, Eugenia
    Gutierrez, Elena
    Cabello, Mercedes
    Casas-Gonzalez, Cristina
    Pozo-Alvarez, Rafael
    Delgado-Burgos, Juan
    Hernandez, Domingo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [8] Elevated CD163 Expression on CD14++CD16+Monocytes in Type 2 Diabetes
    Zaharieva, E.
    Vikentieva, E.
    Andreeva, R.
    Popova, D.
    Tsakove, A.
    Kamenov, Z.
    DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (05): : 271 - 276
  • [9] MESENCHYMAL STROMAL CELLS IMPAIR THE DIFFERENTIATION OF CD14++CD16-CD64+ CLASSICAL MONOCYTES INTO CD14++CD16+CD64++ ACTIVATE MONOCYTES
    Du Rocher, B.
    Mencalha, A.
    Gomes, B. E.
    Bouzas, L. F.
    Abdelhay, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S265 - S266
  • [10] UNIQUE CHARACTERISTICS OF CD14++CD16+MONOCYTES IN PATIENTS WITH ACUTE HEART FAILURE AND IMPLICATIONS FOR CLINICAL OUTCOME
    Wrigley, B. J.
    Shantsila, E.
    Tapp, L.
    Lip, G. Y. H.
    HEART, 2012, 98 : A64 - A65
12345